Sustained efficacy of mirikizumab in moderate-to-severe Crohn’s disease Principal InvestigatorProf. Bruce E. Sands, Icahn School of Medicine at Mount Sinai, NY, USA TrialPhase 2, SERENITY ConferenceUEGW 2020 2 November, 2020 12:20
